Glaxosmithkline Pharmaceuticals
GLAXO · Pharma > Pharmaceuticals & Drugs · Chairman: R S Karnad · MD: S Venkatesh · Listing date: Oct. 25, 1994 · Employees: 4283 · Mumbai · http://india-pharma.gsk.com

Stock Price vs Company Growth
1d
4.3%
1w
5.0%
1m
7.8%
3m
40.2%
6m
6.3%
1y
53.2%
5y
17.5%
10y
8.0%
all
11.6%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec10Jun14Dec17Jun21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

2,866 4.3%
1,924
2,975
Company Overview

Sales
3,705 Cr
Growth: 6.3%
Profit after Tax
852 Cr
Growth: 27.6%
Large Cap
48,543 Cr
P/E: 56.5x
Industry P/E: 29.5x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 3,705
Growth 6.3%
EBITDA 29.7%
P/S 13.1x
Dividend 1.7%
P/E 56.5x
Book Value ₹ 144
PEG Ratio 8.6x
ROE 40.7%
P/B 19.1x
Shareholding Pattern

Institutions
Qualified Institutional Buyer
5.33 %
Life Insurance Corporation Of India
4.78 %
Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Nifty Midcap 150 Index Fund
3.47 %
General Insurance Corporation Of India
1.42 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21Mar22
Promoters
Glaxo Group Limited
35.99 %
Glaxosmithkline Pte Limited
28.1 %
Eskaylab Limited
6.94 %
Burroughs Wellcome International Limited
3.97 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21Mar22
Others
Iepf
0.23 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21Mar22
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies.
Investors (37)
Followers (11)